Qingdao Vland Biotech Co Ltd (603739) — Capital Reinvestment Ratio
Qingdao Vland Biotech Co Ltd (603739) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥24.29 Million) in capital expenditures (CN¥7.42 Million). See 603739 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Qingdao Vland Biotech Co Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks Qingdao Vland Biotech Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check Qingdao Vland Biotech Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Qingdao Vland Biotech Co Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for Qingdao Vland Biotech Co Ltd from 2014 to 2024. For live market cap and broader valuation context, see market value of Qingdao Vland Biotech Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.54x | CN¥195.41 Million | CN¥104.72 Million | ▼ -61.8% |
| 2023 | 1.40x | CN¥153.59 Million | CN¥215.64 Million | ▼ -60.9% |
| 2022 | 3.59x | CN¥95.31 Million | CN¥342.02 Million | ▼ -34.9% |
| 2021 | 5.51x | CN¥89.51 Million | CN¥493.58 Million | ▲ +350.3% |
| 2020 | 1.22x | CN¥173.00 Million | CN¥211.83 Million | ▼ -33.4% |
| 2019 | 1.84x | CN¥65.33 Million | CN¥120.17 Million | ▲ +120.4% |
| 2018 | 0.83x | CN¥85.75 Million | CN¥71.56 Million | ▲ +75.3% |
| 2017 | 0.48x | CN¥121.90 Million | CN¥58.05 Million | ▲ +177.1% |
| 2016 | 0.17x | CN¥154.49 Million | CN¥26.55 Million | ▼ -76.9% |
| 2015 | 0.74x | CN¥74.27 Million | CN¥55.32 Million | ▼ -14.4% |
| 2014 | 0.87x | CN¥58.55 Million | CN¥50.93 Million | — |